genedrive plc (AIM: GDR)
Health Care · Life Sciences Tools & Services · GB
£0.01
+8.33% today · +67.7% 1Y
genedrive plc (AIM: GDR) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $28.45M.
Over the last twelve months the share price has gained 67.7%, trading between 0.00 and 0.02.
Tweenvest scores genedrive plc across four factors: quality 13/100, value 83/100, growth 17/100. Its strongest factor is value.
GDR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $28.45M
- Revenue (TTM)
- $1.58M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.97
- 52-week high
- £0.02
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.61B
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $628.15 | -0.09% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.99 | +0.01% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF592.80 | -0.17% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $153.70 | -0.69% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $261.00 | +0.61% |
| Waters CorporationNYSE: WAT | $40.72B | $418.99 | +1.10% |
Figures last refreshed Aug 18, 2026.